Page 6 - Stan Erck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mutations: Does SARS-CoV-2 Have a Fixed Number of Moves in Its Arsenal? 05/04/2021 National Institutes of Health Director Francis S. Collins holds a model of SARS-CoV-2 as he testifies on Capitol Hill, July 2, 2020. Photo: Graeme Jennings/Pool via Reuters/File Photo London/Chicago: The rapid rise in different parts of the world of deadly, more infectious coronavirus variants that share new mutations is leading scientists to ask a critical question – has the SARS-CoV-2 virus shown its best cards? New variants first detected in such far-flung countries as Brazil, South Africa and...

Apr 1, 2021 LONDON/CHICAGO – The rapid rise in various parts of the world of deadly, more infectious COVID-19 variants that share new mutations is leading scientists to ask a critical question — has the SARS-CoV-2 virus shown its best cards? New variants first detected in such far-flung countries as Brazil, South Africa and the U.K. cropped up spontaneously, within a few months, late last year. All three share some of the same mutations in the important spike region of the virus used to enter and infect cells. These include the E484k mutation, nicknamed “Eek” by some scientis...

MEPs directed their anger at AstraZeneca CEO Pascal Soriot as they sought greater clarity on vaccine deliveries and explanations for ongoing shortages. Soriot took part in a virtual hearing of the European Parliament on Thursday afternoon alongside other CEOs from the pharmaceutical companies that have signed vaccine contracts with the European Commission, including CureVac, Novavax and Moderna. The AstraZeneca chief said the company will provide the EU with 40 million doses in the first quarter of this year. This represents a marked decrease from the original commitment, which ranged between...

Merck is in talks to potentially help with producing COVID-19 vaccines, a spokesman said. (Merck) After Merck & Co. got off to a late start in the COVID-19 vaccine race and made an early exit, the drug giant is in talks to aid the global vaccine manufacturing effort. The drugmaker is “actively involved” in discussions with governments, health agencies and other pharmaceutical companies to “identify the areas of pandemic response where we can play a role, including potential support for production of authorized vaccines," a spokesman said via email. News of the talks comes about two week...

By ROBERT LANGRETH | Bloomberg | Published: February 1, 2021 Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription. A COVID-19 mutation that likely confers partial resistance to the antibodies produced by vaccines is now in the U.S., spurring scientists to probe new ways to battle a disease that's constantly changing and could remain active for years. The South African variant has already spread quickly across the African con...